Searching for smart, safe news you can TRUST?
Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Gerry Broome / AP
Two treatments currently on the "verge of approval" could help reduce the risk of life-threatening reactions for those with peanut allergies, the Financial Times reports in a long read that includes several interesting takeaways:
- One drug is a capsule containing peanut proteins that would be sprinkled over foods. The other is a patch that would be placed on the skin. Both are based on the idea that trace amounts of peanuts, increased over time, can reduce the risk of a serious reaction.
- Three million people have allergies to peanuts and/or tree nuts, and the rate of peanut allergies among children has quadrupled since 1997.
- One possible reason? Between 2000-2008 parents were told not to give children peanuts. That turned out to be precisely the wrong advice.
- There's no simple solution currently available. These treatments would require regular doctor's visits and likely lead to hives, stomach aches and other reactions.